The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
1185820611 11858206 11 F 201509 20160715 20151222 20160722 EXP MX-BAYER-2015-435880 BAYER 69.00 YR E M Y 69.00000 KG 20160722 CN MX MX

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
1185820611 11858206 1 PS NEXAVAR SORAFENIB 1 Oral 400 MG, BID 21923 400 MG FILM-COATED TABLET BID
1185820611 11858206 2 SS NEXAVAR SORAFENIB 1 Oral 400 MG, BID 21923 400 MG FILM-COATED TABLET BID
1185820611 11858206 3 SS NEXAVAR SORAFENIB 1 Oral 600 MG, QD (THREE TABLETS) 21923 600 MG FILM-COATED TABLET QD
1185820611 11858206 4 SS NEXAVAR SORAFENIB 1 Oral 600 MG, QD 21923 600 MG FILM-COATED TABLET QD
1185820611 11858206 5 SS NEXAVAR SORAFENIB 1 Oral 400 MG, BID 21923 400 MG FILM-COATED TABLET BID
1185820611 11858206 6 C METAMIZOLE METAMIZOLE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
1185820611 11858206 1 Renal cell carcinoma
1185820611 11858206 2 Renal cell carcinoma
1185820611 11858206 3 Renal cell carcinoma
1185820611 11858206 4 Renal cell carcinoma
1185820611 11858206 5 Renal cell carcinoma

Outcome of event

Event ID CASEID OUTC COD
1185820611 11858206 OT
1185820611 11858206 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
1185820611 11858206 Abasia
1185820611 11858206 Abdominal distension
1185820611 11858206 Abdominal hernia
1185820611 11858206 Abdominal pain
1185820611 11858206 Abdominal pain upper
1185820611 11858206 Asthenia
1185820611 11858206 Blood cholesterol increased
1185820611 11858206 Blood glucose increased
1185820611 11858206 Blood triglycerides increased
1185820611 11858206 Cancer pain
1185820611 11858206 Cheilitis
1185820611 11858206 Decreased appetite
1185820611 11858206 Diarrhoea
1185820611 11858206 Dizziness
1185820611 11858206 Ear pain
1185820611 11858206 Erythema
1185820611 11858206 Feeling abnormal
1185820611 11858206 Flatulence
1185820611 11858206 Gait disturbance
1185820611 11858206 Gastric disorder
1185820611 11858206 Gastric infection
1185820611 11858206 Gout
1185820611 11858206 Grief reaction
1185820611 11858206 Hospitalisation
1185820611 11858206 Hyperkeratosis
1185820611 11858206 Hypertension
1185820611 11858206 Limb discomfort
1185820611 11858206 Metastases to bone
1185820611 11858206 Nightmare
1185820611 11858206 Pain in extremity
1185820611 11858206 Pain of skin
1185820611 11858206 Palmar-plantar erythrodysaesthesia syndrome
1185820611 11858206 Peripheral swelling
1185820611 11858206 Poor peripheral circulation
1185820611 11858206 Scab
1185820611 11858206 Skin discolouration
1185820611 11858206 Skin fissures
1185820611 11858206 Toxicity to various agents
1185820611 11858206 Tremor
1185820611 11858206 Vision blurred
1185820611 11858206 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
1185820611 11858206 1 201207 201509 0
1185820611 11858206 2 20151008 0